NCT02184897View on ClinicalTrials.gov

Pharmacokinetic and Pharmacodynamic Study of Lenograstim for Hematopoietic Stem Cell Mobilization

NAUnknownINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

July 31, 2014

Primary Completion Date

August 31, 2016

Study Completion Date

December 31, 2016

Conditions
Multiple Myeloma
Interventions
DRUG

lenograstim 10 microgram/kg/day

Trial Locations (2)

138-736

Asan Medical Center, University of Ulsan College of Medicine, Seoul

1387-736

Asan Medical Center, Seoul

Sponsors
All Listed Sponsors
lead

Asan Medical Center

OTHER

NCT02184897 - Pharmacokinetic and Pharmacodynamic Study of Lenograstim for Hematopoietic Stem Cell Mobilization | Biotech Hunter | Biotech Hunter